Cited by 1,075Schizophrenia research and treatmentNeuroscience and Neuropharmacology ResearchNeurotransmitter Receptor Influence on Behavior

The DOI matches its Crossref record; 63 of the 64 references it cites were found in a registry or an index.

Mice with Reduced NMDA Receptor Expression Display Behaviors Related to Schizophrenia

Open access

Mohn, Amy R, Gainetdinov, Raul R, Caron, Marc G, Koller, Beverly H·1999·Cell

DOI 10.1016/s0092-8674(00)81972-8

Open this paper in CoChat — free account Open PDF

Abstract

N-methyl-D-aspartate receptors (NMDARs) represent a subclass of glutamate receptors that play a critical role in neuronal development and physiology. We report here the generation of mice expressing only 5% of normal levels of the essential NMDAR1 (NR1) subunit. Unlike NR1 null mice, these mice survive to adulthood and display behavioral abnormalities, including increased motor activity and stereotypy and deficits in social and sexual interactions. These behavioral alterations are similar to those observed in pharmacologically induced animal models of schizophrenia and can be ameliorated by treatment with haloperidol or clozapine, antipsychotic drugs that antagonize dopaminergic and serotonergic receptors. These findings support a model in which reduced NMDA receptor activity results in schizophrenic-like behavior and reveals how pharmacological manipulation of monoaminergic pathways can affect this phenotype.

Integrity signals

Registry

Crossref · 10.1016/s0092-8674(00)81972-8

Cites

63 of 63 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The Mouse Brain in Stereotaxic Coordinates
Paxinos, G. (2001) · Cited by 12,859
mouse brain in stereotaxic coordinates
Franklin, K. B. J., & Paxinos, G. (1997) · Cited by 3,258
Recent advances in the phencyclidine model of schizophrenia
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.10.1301 · Cited by 2,904
Heteromeric NMDA receptors: molecular and functional distinction of subtypes
Monyer, H., Sprengel, R., Schoepfer, R., Herb, A., Higuchi, M., Lomeli, H., Burnashev, N., Sakmann, B., & Seeburg, P. H. (1992) · Science · doi:10.1126/science.256.5060.1217 · Cited by 2,541
Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter
Giros, B., Jaber, M., Jones, S. R., Wightman, R. M., & Caron, M. G. (1996) · Nature · doi:10.1038/379606a0 · Cited by 2,476
Self-citation
Antipsychotic drug doses and neuroleptic/dopamine receptors
SEEMAN, P., LEE, T., CHAU-WONG, M., & WONG, K. (1976) · Nature · doi:10.1038/261717a0 · Cited by 1,622
Behavioral phenotypes of inbred mouse strains: implications and recommendations for molecular studies
Crawley, J. N., Belknap, J. K., Collins, A. C., Crabbe, J. C., Frankel, W. N., Henderson, N. D., HITZEMANN, R. J., Maxson, S. C., Miner, L. L., Silva, A. J., et al. (1997) · Psychopharmacology · doi:10.1007/s002130050327 · Cited by 1,372
Molecular diversity of the NMDA receptor channel
Kutsuwada, T., Kashiwabuchi, N., Mori, H., Sakimura, K., Kushiya, E., Araki, K., Meguro, H., Hisashi, M., Kumanishi, T., Arakawa, M., et al. (1992) · Nature · doi:10.1038/358036a0 · Cited by 1,352
HPRT-deficient (Lesch–Nyhan) mouse embryos derived from germline colonization by cultured cells
Hooper, M., Hardy, K., Handyside, A. H., Hunter, S., & Monk, M. (1987) · Nature · doi:10.1038/326292a0 · Cited by 1,218
Interactions between glutamatergic and monoaminergic systems within the basal ganglia-implications for schizophrenia and Parkinson's disease
Carlsson, M. L., & Carlsson, A. (1990) · Trends in Neurosciences · doi:10.1016/0166-2236(90)90108-m · Cited by 1,086

Show all 64 references

Research works printed but not linked: 2

Ereshefsky, 1989, Clozapine, Clin. Pharm., 8, 691
Rosenbauer, 1980, Studies concerning the formation of vaginal plug in laboratory animals and its suitability for demonstrating the ultrastructure of spermatazoa, Folia Morphol. (Praha), 28, 126

Sorted by citations

Items 101–200 of 1,000

Glutamate Neurocircuitry: Theoretical Underpinnings in Schizophrenia
Schwartz, T. L., Sachdeva, S., & Stahl, S. M. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00195 · Cited by 201
Deletion of CB2 Cannabinoid Receptor Induces Schizophrenia-Related Behaviors in Mice
Ortega-Álvaro, A., Aracil-Fernández, A., García‐Gutiérrez, M. S., Navarrete, F., & Manzanares, J. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.34 · Cited by 190
NMDA receptors, cognition and schizophrenia – Testing the validity of the NMDA receptor hypofunction hypothesis
Gilmour, G., Dix, S. L., Fellini, L., Gastambide, F., Plath, N., Steckler, T., Talpos, J. C., & Tricklebank, M. D. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.03.015 · Cited by 190
Clozapine and Haloperidol Differently Suppress the MK-801-Increased Glutamatergic and Serotonergic Transmission in the Medial Prefrontal Cortex of the Rat
López-Gil, X., Babot, Z., Amargós-Bosch, M., Suñol, C., Artigas, F., & Adell, A. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301356 · Cited by 183
Advancing schizophrenia drug discovery: optimizing rodent models to bridge the translational gap
Pratt, J. A., Winchester, C. L., Dawson, N., & MORRIS, B. J. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3649 · Cited by 199
A Placebo-Controlled Add-On Trial of the Ampakine, CX516, for Cognitive Deficits in Schizophrenia
GOFF, D. C., Lamberti, J. S., Leon, A. C., Green, M. F., Miller, A. L., Patel, J. K., Manschreck, T. C., Freudenreich, O., & Johnson, S. A. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301444 · Cited by 181
Altered Social Behaviours in Neurexin 1α Knockout Mice Resemble Core Symptoms in Neurodevelopmental Disorders
Grayton, H. M., Missler, M., Collier, D. A., & Fernandes, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067114 · Cited by 187
A Critical Role for GluN2B-Containing NMDA Receptors in Cortical Development and Function
Wang, C.-C., Held, R. G., Chang, S.-C., Yang, L., Delpire, E., Ghosh, A., & Hall, B. J. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.023 · Cited by 180
Mice lacking the AMPA GluR1 receptor exhibit striatal hyperdopaminergia and ‘schizophrenia-related’ behaviors
Wiedholz, L. M., Owens, W. A., Horton, R. E., Feyder, M. J., Karlsson, R.-M., Hefner, K. R., Sprengel, R., Celikel, T., Daws, L. C., & Holmes, A. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4002056 · Cited by 180
Positive Allosteric Modulators of GluN2A-Containing NMDARs with Distinct Modes of Action and Impacts on Circuit Function
Hackos, D. H., Lupardus, P. J., Grand, T., Chen, Y., Wang, T.-M., Reynen, P., Gustafson, A. E., Wallweber, H. J. A., Volgraf, M., Sellers, B. D., et al. (2016) · Neuron · doi:10.1016/j.neuron.2016.01.016 · Cited by 174
d-serine augments NMDA-NR2B receptor-dependent hippocampal long-term depression and spatial reversal learning
Duffy, S., Labrie, V., & Roder, J. C. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301486 · Cited by 173
The neuregulin signaling pathway and schizophrenia: From genes to synapses and neural circuits
Buonanno, A. (2010) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2010.07.012 · Cited by 173
Kalirin regulates cortical spine morphogenesis and disease-related behavioral phenotypes
Cahill, M. E., Xie, Z., Day, M., Photowala, H., Barbolina, M. V., Miller, C. A., Weiss, C., Radulovic, J., Sweatt, J. D., Disterhoft, J. F., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904636106 · Cited by 170
Influence of the NR3A subunit on NMDA receptor functions
Henson, M. A., Roberts, A. C., Pérez‐Otaño, I., & Philpot, B. D. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.01.004 · Cited by 195
E-I balance and human diseases – from molecules to networking
Eichler, S. A. (2008) · Frontiers in Molecular Neuroscience · doi:10.3389/neuro.02.002.2008 · Cited by 169
Glutamatergic modulation of hyperactivity in mice lacking the dopamine transporter
Gainetdinov, R. R., Mohn, A. R., Bohn, L., & Caron, M. G. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191353298 · Cited by 168
Self-citation
Selective up-regulation of dopamine D1 receptors in dendritic spines by NMDA receptor activation
Scott, L., Kruse, M. S., Forssberg, H., Brismar, H., Greengard, P., & Aperia, A. C. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.032654599 · Cited by 168
The suppression of brain cold-stable microtubules in mice induces synaptic defects associated with neuroleptic-sensitive behavioral disordersPreprint
Andrieux, A., Salin, P. A., Vernet, M., Kujala, P., Baratier, J., Gory‐Fauré, S., Bosc, C., Pointu, H., Proietto, D., Schweitzer, A., et al. (2002) · Genes & Development · doi:10.1101/gad.223302 · Cited by 187
Toxoplasma gondiiinfection, from predation to schizophrenia: can animal behaviour help us understand human behaviour?
Webster, J. P., Kaushik, M., Bristow, G. C., & McConkey, G. A. (2012) · Journal of Experimental Biology · doi:10.1242/jeb.074716 · Cited by 175
The contribution of GABAergic dysfunction to neurodevelopmental disorders
Ramamoorthi, K., & Lin, Y. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2011.03.003 · Cited by 173
Genetic association studies of glutamate, GABA and related genes in schizophrenia and bipolar disorder: A decade of advance
Cherlyn, S. Y. T., Woon, P. S., Liu, J., Ong, W., Tsai, G., & Sim, K. (2010) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.01.002 · Cited by 165
Heteromeric Dopamine Receptor Signaling Complexes: Emerging Neurobiology and Disease Relevance
Perreault, M. L., Hasbi, A., O’Dowd, B. F., & George, S. R. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.148 · Cited by 172
Altered motor activity, exploration and anxiety in heterozygous neuregulin 1 mutant mice: implications for understanding schizophrenia
Karl, T., Duffy, L., Scimone, A., Harvey, R. P., & Schofield, P. R. (2006) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2006.00298.x · Cited by 163
Long‐term behavioural, molecular and morphological effects of neonatal NMDA receptor antagonism
Harris, L. W., Sharp, T., Gartlon, J. E., Jones, D. N. C., & Harrison, P. J. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02902.x · Cited by 162
Assessment of NMDA receptor NR1 subunit hypofunction in mice as a model for schizophrenia
Halene, T. B., Ehrlichman, R. S., Liang, Y., Christian, E. P., Jonak, G. J., Gur, T., Blendy, J. A., Dow, H. C., Brodkin, E. S., Schneider, F. W., et al. (2009) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2009.00504.x · Cited by 162
NMDAR Hypofunction Animal Models of Schizophrenia
Lee, G. S., & Zhou, Y. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00185 · Cited by 168
Regulation of NMDA Receptors by Dopamine D4Signaling in Prefrontal Cortex
Wang, X., Zhong, P., Gu, Z., & Yan, Z. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-30-09852.2003 · Cited by 159
Implications for reactive oxygen species in schizophrenia pathogenesis
Koga, M., Serritella, A. V., Sawa, A., & Sedlak, T. W. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.06.022 · Cited by 164
Hyperfunction of Dopaminergic and Serotonergic Neuronal Systems in Mice Lacking the NMDA Receptor ε1 Subunit
Miyamoto, Y., Yamada, K., Noda, Y., Mori, H., Mishina, M., & Nabeshima, T. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-02-00750.2001 · Cited by 158
NMDA Receptor Regulation by D-serine: New Findings and Perspectives
Wolosker, H. (2007) · Molecular Neurobiology · doi:10.1007/s12035-007-0038-6 · Cited by 157
Functional hierarchy underlies preferential connectivity disturbances in schizophrenia
Yang, G. J., Murray, J. D., Wang, X.-J., Glahn, D. C., Pearlson, G. D., Repovs, G., Krystal, J. H., & Anticevic, A. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1508436113 · Cited by 153
Neuregulins: Versatile growth and differentiation factors in nervous system development and human disease
Esper, R. M., Pankonin, M. S., & Loeb, J. A. (2006) · Brain Research Reviews · doi:10.1016/j.brainresrev.2005.11.006 · Cited by 152
Glutamate signaling in the pathophysiology and therapy of schizophrenia
Lin, C., Lane, H., & Tsai, G. E. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.03.023 · Cited by 154
Susceptibility genes for schizophrenia: Characterisation of mutant mouse models at the level of phenotypic behaviour
O’Tuathaigh, C. M. P., Babovic, D., O’Meara, G. F., Clifford, J. J., Croke, D. T., & Waddington, J. L. (2006) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2006.04.002 · Cited by 154
Rapid Synaptic Remodeling by Protein Kinase C: Reciprocal Translocation of NMDA Receptors and Calcium/Calmodulin-Dependent Kinase II
Fong, D. K., Rao, A., Crump, F. T., & Craig, A. M. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-06-02153.2002 · Cited by 150
Intracellular Modulation of NMDA Receptor Function by Antipsychotic Drugs
Leveque, J., Macias‐Konstantopoulos, W., Rajadhyaksha, A. M., Carlson, R. R., Barczak, A. K., Kang, S., Li, X., Coyle, J. T., Huganir, R. L., Heckers, S., et al. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-11-04011.2000 · Cited by 148
Genetics of aggressive behavior: An overview
Veroude, K., Zhang‐James, Y., Fernàndez‐Castillo, N., Bakker, M. J., Cormand, B., & Faraone, S. V. (2016) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32364 · Cited by 147
Activation of type 5 metabotropic glutamate receptors enhances NMDA responses in mice cortical wedges
Attucci, S., Carla�, V., Mannaioni, G., & Moroni, F. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703904 · Cited by 147
Disruption of the neuronal PAS3 gene in a family affected with schizophrenia
Kamnasaran, D., Muir, W. J., Ferguson-Smith, M. A., & Cox, D. W. (2003) · Journal of Medical Genetics · doi:10.1136/jmg.40.5.325 · Cited by 146
Dynamic disorganization of synaptic NMDA receptors triggered by autoantibodies from psychotic patients
Jézéquel, J., Johansson, E. M., Dupuis, J. P., Rogemond, V., Gréa, H., Kellermayer, B., Hamdani, N., Guen, E. L., Rabu, C., Lepleux, M., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01700-3 · Cited by 145
Estrogenic modulation of brain activity: implications for schizophrenia and Parkinson’s disease
Cyr, M., Calon, F., Morissette, M., & Paolo, T. D. (2002) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0202 · Cited by 146
Neuregulin 1 and schizophrenia
Stefánsson, H., Steinthórsdóttir, V., Thorgeirsson, T. E., Gulcher, J. R., & Stefánsson, K. (2004) · Annals of Medicine · doi:10.1080/07853890310017585 · Cited by 145
Human serine racemase: moleular cloning, genomic organization and functional analysis
Miranda, J. D., Santoro, A., Engelender, S., & Wolosker, H. (2000) · Gene · doi:10.1016/s0378-1119(00)00356-5 · Cited by 142
Glutamatergic Animal Models of Schizophrenia
Moghaddam, B., & Jackson, M. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1300.065 · Cited by 142
Mice with reduced NMDA receptor glycine affinity model some of the negative and cognitive symptoms of schizophrenia
Labrie, V., Lipina, T. V., & Roder, J. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1196-6 · Cited by 141
cAMP-Dependent Protein Kinase Mediates Activity-Regulated Synaptic Targeting of NMDA Receptors
Crump, F. T., Dillman, K. S., & Craig, A. M. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-14-05079.2001 · Cited by 140
Severe Impairment of NMDA Receptor Function in Mice Carrying Targeted Point Mutations in the Glycine Binding Site Results in Drug-Resistant Nonhabituating Hyperactivity
Ballard, T. M., Pauly-Evers, M., Higgins, G. A., Ouagazzal, A., Mutel, V., Borroni, E., Kemp, J. A., Bluethmann, H., & Kew, J. N. C. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-15-06713.2002 · Cited by 141
DISC1 at 10: connecting psychiatric genetics and neuroscience
Porteous, D. J., Millar, J. K., Brandon, N. J., & Sawa, A. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2011.09.002 · Cited by 140
NAAG peptidase inhibition reduces locomotor activity and some stereotypes in the PCP model of schizophrenia via group II mGluR
Olszewski, R. T., Bukhari‐Parlakturk, N., Zhou, J., Kozikowski, A. P., Wroblewski, J. T., Shamimi-Noori, S. M., Wróblewska, B., Bzdega, T., Vicini, S., Barton, F. B., et al. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02358.x · Cited by 137
Mouse models of autism spectrum disorders: The challenge for behavioral genetics
Moy, S. S., Nadler, J. J., Magnuson, T., & Crawley, J. N. (2006) · American Journal of Medical Genetics Part C Seminars in Medical Genetics · doi:10.1002/ajmg.c.30081 · Cited by 141
Dysbindin deficiency in sandy mice causes reduction of snapin and displays behaviors related to schizophrenia
FENG, Y., ZHOU, Z., HE, X., WANG, H., Guo, X. W., HAO, C., GUO, Y., Zhen, X., & Li, W. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.07.018 · Cited by 140
Neuregulin-1 regulates LTP at CA1 hippocampal synapses through activation of dopamine D4 receptors
Kwon, O. B., Paredes, D., González, C. M., Neddens, J., Hernandez, L., Vullhorst, D., & Buonanno, A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805722105 · Cited by 134
Glial transport of the neuromodulator d-serine
Ribeiro, C. S., Reis, M. M., Panizzutti, R., Miranda, J. D., & Wolosker, H. (2002) · Brain Research · doi:10.1016/s0006-8993(01)03390-x · Cited by 133
Reelin, an extracellular matrix protein linked to early onset psychiatric diseases, drives postnatal development of the prefrontal cortex via GluN2B-NMDARs and the mTOR pathway
Iafrati, J., Orejarena, M. J., Lassalle, O., Bouamrane, L., & Chavis, P. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.66 · Cited by 132
Genetics and Epigenetics in Major Psychiatric Disorders
Abdolmaleky, H. M., Thiagalingam, S., & Wilcox, M. (2005) · American Journal of PharmacoGenomics · doi:10.2165/00129785-200505030-00002 · Cited by 134
Dissection of behavior and psychiatric disorders using the mouse as a model
Tarantino, L. M. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.6.953 · Cited by 130
The cannabinoid receptor 1 associates with NMDA receptors to produce glutamatergic hypofunction: implications in psychosis and schizophrenia
Sánchez‐Blázquez, P., Rodríguez-Muñoz, M., & Garzón, J. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00169 · Cited by 131
NR2B Signaling Regulates the Development of Synaptic AMPA Receptor Current
Hall, B. J., Ripley, B. A., & Ghosh, A. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.3793-07.2007 · Cited by 130
Positive associations of polymorphisms in the metabotropic glutamate receptor type 3 gene ( GRM3 ) with schizophrenia
Fujii, Y., Shibata, H., Kikuta, R., Makino, C., Tani, A., Hirata, N., Shibata, A., Ninomiya, H., Tashiro, N., & Fukumaki, Y. (2003) · Psychiatric Genetics · doi:10.1097/01.ypg.0000056682.82896.b0 · Cited by 129
Mammalian Reverse Genetics without Crossing Reveals Nr3a as a Short-Sleeper Gene
Sunagawa, G. A., Sumiyama, K., Ukai‐Tadenuma, M., Perrin, D., Fujishima, H., Ukai, H., Nishimura, O., Shi, S., Ohno, R.-I., Narumi, R., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2015.12.052 · Cited by 126
Clozapine, but not haloperidol, reverses social behavior deficit in mice during withdrawal from chronic phencyclidine treatment
Qiao, H., Noda, Y., Kamei, H., Nagai, T., Furukawa, H., Miura, H., Kayukawa, Y., Ohta, T., & Nabeshima, T. (2001) · Neuroreport · doi:10.1097/00001756-200101220-00010 · Cited by 128
Spine pruning drives antipsychotic-sensitive locomotion via circuit control of striatal dopamine
Kim, I. H., Rossi, M. A., Aryal, D. K., Racz, B., Kim, N., Uezu, A., Wang, F., Wetsel, W. C., Weinberg, R. J., Yin, H., et al. (2015) · Nature Neuroscience · doi:10.1038/nn.4015 · Cited by 127
NMDA Receptor Function, Neuroplasticity, and the Pathophysiology of Schizophrenia
Coyle, J. T., & Tsai, G. E. (2004) · International review of neurobiology · doi:10.1016/s0074-7742(04)59019-0 · Cited by 128
Neuronal signaling and the regulation of bone remodeling
Elefteriou, F. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5175-3 · Cited by 131
Activation of 5-HT2A/C Receptors Counteracts 5-HT1A Regulation of N-Methyl-D-aspartate Receptor Channels in Pyramidal Neurons of Prefrontal Cortex
Yuen, E. Y., Jiang, Q., Chen, P., Feng, J., & Yan, Z. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801713200 · Cited by 125
Developmental vulnerability of synapses and circuits associated with neuropsychiatric disorders
Penzes, P., Buonanno, A., Passafaro, M., Sala, C., & Sweet, R. A. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12261 · Cited by 125
TAAR1 Modulates Cortical Glutamate NMDA Receptor Function
Espinoza, S., Lignani, G., Caffino, L., Maggi, S., Sukhanov, I., Leo, D., Mus, L., Emanuele, M., Ronzitti, G., Harmeier, A., et al. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.65 · Cited by 125
Self-citation
Neural Cell Adhesion Molecule-Secreting Transgenic Mice Display Abnormalities in GABAergic Interneurons and Alterations in Behavior
Pillai-Nair, N., Panicker, A. K., Rodriguiz, R. M., Gilmore, K. L., Demyanenko, G. P., Huang, Z. J., Wetsel, W. C., & Maness, P. F. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.0565-05.2005 · Cited by 125
Mice with reduced NMDA receptor expression: more consistent with autism than schizophrenia?
Gandal, M. J., Anderson, R. L., Billingslea, E. N., Carlson, G. C., Roberts, T. P. L., & Siegel, S. J. (2012) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2012.00816.x · Cited by 122
Mechanisms underlying autoimmune synaptic encephalitis leading to disorders of memory, behavior and cognition: insights from molecular, cellular and synaptic studies
Moscato, E. H., Jain, A., Peng, X., Hughes, E. G., Dalmau, J. O., & Balice‐Gordon, R. J. (2010) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2010.07349.x · Cited by 125
Why glycine transporters have different stoichiometries
Supplisson, S., & Roux, M. J. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03251-9 · Cited by 122
Selective reduction of a PDZ protein, SAP‐97, in the prefrontal cortex of patients with chronic schizophrenia
Toyooka, K., Iritani, S., Makifuchi, T., Shirakawa, O., Kitamura, N., Maeda, K., Nakamura, R., Niizato, K., Watanabe, M., Kakita, A., et al. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01181.x · Cited by 121
Reduced expression of the NMDA receptor-interacting protein SynGAP causes behavioral abnormalities that model symptoms of Schizophrenia
Guo, X., Hamilton, P. J., Reish, N. J., Sweatt, J. D., Miller, C. A., & Rumbaugh, G. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.223 · Cited by 120
Mice with Very Low Expression of the Vesicular Monoamine Transporter 2 Gene Survive into Adulthood: Potential Mouse Model for Parkinsonism
Mooslehner, K. A., Chan, P. M., Xu, W., Liu, L., Smadja, C., Humby, T., Allen, N. D., Wilkinson, L. S., & Emson, P. C. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.16.5321-5331.2001 · Cited by 118
Loss of G Protein γ7 Alters Behavior and Reduces Striatal αolf Level and cAMP Production
Schwindinger, W. F., Betz, K. S., Giger, K. E., Sabol, A., Bronson, S. K., & Robishaw, J. D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211132200 · Cited by 119
Contributions of the d-serine pathway to schizophrenia
Labrie, V., Wong, A. H. C., & Roder, J. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.01.030 · Cited by 121
Catatonia
Walther, S., & Strik, W. K. (2016) · CNS Spectrums · doi:10.1017/s1092852916000274 · Cited by 118
Adult mice with reduced Nurr1 expression: an animal model for schizophrenia
Rojas, P., Joodmardi, E., Hong, Y., Perlmann, T., & Ögren, S. O. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001993 · Cited by 120
Therapeutic potential of N-methyl-D-aspartate receptor modulators in psychiatry
Hanson, J. E., Yuan, H., Perszyk, R. E., Banke, T. G., Xing, H., Tsai, M., Menniti, F. S., & Traynelis, S. F. (2023) · Neuropsychopharmacology · doi:10.1038/s41386-023-01614-3 · Cited by 121
Association of the glutamate receptor subunit gene GRIN2B with attention‐deficit/hyperactivity disorder
Dorval, K. M., Wigg, K., Crosbie, J., Tannock, R., Kennedy, J. L., Ickowicz, A., Pathare, T., MALONE, M. A., Schachar, R. J., & Barr, C. L. (2006) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2006.00273.x · Cited by 120
PSD-95 stabilizes NMDA receptors by inducing the degradation of STEP 61
Won, S., Incontro, S., Nicoll, R. A., & Roche, K. W. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1609702113 · Cited by 125
STOP knockout and NMDA NR1 hypomorphic mice exhibit deficits in sensorimotor gating
Fradley, R. L., O’Meara, G. F., Newman, R. J., Andrieux, A., Job, D., & Reynolds, D. S. (2005) · Behavioural Brain Research · doi:10.1016/j.bbr.2005.05.012 · Cited by 127
The changing roles and targets for animal models of schizophrenia
Kilts, C. D. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01286-0 · Cited by 116
The involvement of the NMDA receptor d-serine/glycine site in the pathophysiology and treatment of schizophrenia
Labrie, V., & Roder, J. (2009) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.08.002 · Cited by 118
RETRACTED: Enhanced Polyubiquitination of Shank3 and NMDA Receptor in a Mouse Model of Autism
Bangash, M. A., Park, J. M., Melnikova, T., Wang, D., Jeon, S. K., Lee, D., Syeda, S. K., Kim, J., Kouser, M., Schwartz, J. L., et al. (2011) · Cell · doi:10.1016/j.cell.2011.03.052 · Cited by 116
Retracted
Modulation of NMDA Receptors by Pituitary Adenylate Cyclase Activating Peptide in CA1 Neurons Requires Gαq, Protein Kinase C, and Activation of Src
Macdonald, D. S., Weerapura, M., Beazely, M. A., Martin, L. J., Czerwinski, W., Roder, J., Orser, B. A., & MacDonald, J. F. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.3871-05.2005 · Cited by 115
Serine racemase deletion disrupts memory for order and alters cortical dendritic morphology
DeVito, L. M., Balu, D. T., Kanter, B. R., Lykken, C., Basu, A. C., COYLE, J. T., & Eichenbaum, H. (2010) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2010.00656.x · Cited by 114
Cytogenetic and genetic evidence supports a role for the kainate-type glutamate receptor gene, GRIK4, in schizophrenia and bipolar disorder
Pickard, B. S., Malloy, M. P., Christoforou, A., Thomson, P. A., Evans, K. L., Morris, S. W., Hampson, M. E., Porteous, D. J., Blackwood, D., & Muir, W. J. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001867 · Cited by 116
Postmortem Brain: An Underutilized Substrate for Studying Severe Mental Illness
McCullumsmith, R. E., Hammond, J. H., Shan, D., & Meador‐Woodruff, J. H. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.239 · Cited by 115
Glutamate in schizophrenia: Neurodevelopmental perspectives and drug development
Egerton, A., Grace, A. A., Stone, J. M., Bossong, M. G., Sand, M. S., & McGuire, P. K. (2020) · Schizophrenia Research · doi:10.1016/j.schres.2020.09.013 · Cited by 118
Npas4: A Neuronal Transcription Factor with a Key Role in Social and Cognitive Functions Relevant to Developmental Disorders
Coutellier, L. D., Beraki, S., Ardestani, P. M., Saw, N. L., & Shamloo, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046604 · Cited by 112
Spatial and temporal boundaries of NMDA receptor hypofunction leading to schizophrenia
Nakazawa, K., Jeevakumar, V., & Nakao, K. (2017) · npj Schizophrenia · doi:10.1038/s41537-016-0003-3 · Cited by 110
Serine Racemase Deletion Protects Against Cerebral Ischemia and Excitotoxicity
Mustafa, A. K., Ahmad, A. S., Zeynalov, E., Gazi, S. K., Sikka, G., Ehmsen, J. T., Barrow, R. K., Coyle, J. T., Snyder, S. H., & Doré, S. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.4297-09.2010 · Cited by 115
Neurobehavioral abnormalities in the dysbindin‐1 mutant, sandy, on a C57BL/6J genetic background
Cox, M. M., Tucker, A. M., Tang, J., Talbot, K., Richer, D. C., Yeh, L., & Arnold, S. E. (2009) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2009.00477.x · Cited by 110
Phenotypic Characterization of Transgenic Mice Overexpressing Neuregulin-1
Kato, T., Kasai, A., Mizuno, M., Fengyi, L., Shintani, N., Maeda, S., Yokoyama, M., Ozaki, M., & Nawa, H. (2010) · PLoS ONE · doi:10.1371/journal.pone.0014185 · Cited by 114
Genetic Mouse Models of Schizophrenia: From Hypothesis-Based To Susceptibility Gene-Based Models
Chen, J., Lipska, B. K., & Weinberger, D. R. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.02.024 · Cited by 108
Cortical Oscillations in Health and Disease
Traub, R. D., & Whittington, M. A. (2010) · doi:10.1093/acprof:oso/9780195342796.001.0001 · Cited by 108
Stress-Induced Changes of Hippocampal NMDA Receptors: Modulation by Duloxetine Treatment
Calabrese, F., Guidotti, G., Molteni, R., Racagni, G., Mancini, M., & Riva, M. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037916 · Cited by 107
Defects in Bioenergetic Coupling in Schizophrenia
Sullivan, C. R., O'Donovan, S. M., McCullumsmith, R. E., & Ramsey, A. J. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.10.014 · Cited by 108
Pharmacological modulation of AMPA receptor rescues social impairments in animal models of autism
Kim, J., Park, K., Kang, R. J., Gonzales, E. L., Kim, D. G., Oh, H. A., Seung, H., Ko, M. J., Kwon, K. J., Kim, K. C., et al. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0098-5 · Cited by 111

Authors: Mohn, A. R., Gainetdinov, R. R., Caron, M. G., & Koller, B. H.
Affiliations: University of North Carolina at Chapel Hill (US)
Howard Hughes Medical Institute (US)
Corresponding author: Koller, Beverly H
ORCID: Gainetdinov, Raul R
Caron, Marc G
Koller, Beverly H
Venue: Cell
Publisher: Elsevier BV
Published: 1999-08
Volume: 98
Issue: 4
Pages: 427-436
ISSN: 0092-8674 (ISSN-L)
DOI: 10.1016/s0092-8674(00)81972-8
OpenAlex: W2164674870
Cited by: 1,075
References: 64
Citations by year: 2026: 13 · 2025: 14 · 2024: 19 · 2023: 17 · 2022: 28 · 2021: 26 · 2020: 26 · 2019: 28 · 2018: 29 · 2017: 27 · 2016: 46 · 2015: 40 · 2014: 39 · 2013: 42 · 2012: 45
FWCI: 24.23
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 5099 d)
Locations: Cell (publishedVersion)
PubMed (publishedVersion)
Funders: National Institute of General Medical Sciences (T32GM007092, T32 GM07092)
National Institute of Neurological Disorders and Stroke (NS-19576, R01NS019576)
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Keywords: NMDA receptor, NR1 subunit, schizophrenia, mouse model, motor activity, stereotypy, social interaction deficits, antipsychotic drugs, haloperidol, clozapine, monoaminergic pathways, glutamate receptors
MeSH terms: Animals, Antisocial Personality Disorder, Behavior, Animal, Clozapine, Disease Models, Animal, Female, Haloperidol, Male, Motor Activity, Phencyclidine, Schizophrenic Psychology, Serotonin Antagonists, Sexual Behavior, Animal, Social Behavior, Stereotyped Behavior, Antipsychotic Agents, Receptors, N-Methyl-D-Aspartate, Dizocilpine Maleate, Mice, Knockout, Dopamine Antagonists, Excitatory Amino Acid Antagonists, Glutamic Acid, Calcium Signaling, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Mice with Reduced NMDA Receptor Expression Display Behaviors Related to Schizophrenia

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks